What biochemical findings confirm a diagnosis of polycystic ovarian syndrome (PCOS) in a patient with polycystic ovaries on ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Biochemical Findings Confirming PCOS Diagnosis

The correct answer is D: High Free Androgen Index, High free testosterone—these are the key biochemical markers that confirm PCOS diagnosis in a patient with polycystic ovaries on ultrasound and clinical features of the syndrome. 1

Diagnostic Framework

PCOS diagnosis requires at least 2 of 3 Rotterdam criteria: hyperandrogenism (clinical or biochemical), ovulatory dysfunction, and polycystic ovary morphology on ultrasound. 1, 2 Since this patient already has polycystic ovaries on ultrasound and suspected clinical features, biochemical confirmation of hyperandrogenism completes the diagnosis. 1

First-Line Biochemical Tests for PCOS

The diagnostic workup should prioritize:

  • Total testosterone has 74% sensitivity and 86% specificity for PCOS diagnosis 1
  • Free testosterone (calculated or measured by equilibrium dialysis) has the highest sensitivity at 89% with 83% specificity 1, 2
  • Free Androgen Index (FAI) has 78% sensitivity and 85% specificity for PCOS diagnosis 1, 2

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the preferred measurement method due to superior accuracy compared to direct immunoassays, which have lower sensitivity and specificity. 1, 2

Why Other Options Are Incorrect

Option A (Normal range LH, FSH, and free testosterone)

  • Normal androgens would not confirm PCOS diagnosis 1
  • While LH/FSH ratio >2 may suggest PCOS, this is a second-line test and normal values don't exclude the diagnosis 3

Option B (High 17-hydroxyprogesterone)

  • Elevated 17-hydroxyprogesterone suggests non-classic congenital adrenal hyperplasia, which is a differential diagnosis that must be excluded, not a confirmatory finding for PCOS 2, 3

Option C (Testosterone very high, FSH and LH normal)

  • Very high testosterone (particularly rapid onset with severe hyperandrogenism) raises concern for androgen-secreting tumors of the ovary or adrenal gland, requiring urgent evaluation 2, 3
  • This pattern warrants exclusion of malignancy rather than confirming PCOS 2

Option E (High CA125 and CEA)

  • These are tumor markers with no role in PCOS diagnosis 1, 2

Critical Considerations for This 17-Year-Old Patient

Ultrasound should not be used as a primary diagnostic criterion in adolescents <8 years post-menarche due to high false-positive rates from normal multi-follicular ovaries in this age group. 4, 2 However, if polycystic ovaries are already documented and clinical features are present, biochemical hyperandrogenism (elevated free testosterone and FAI) provides the necessary confirmation. 1, 2

Additional Differential Diagnosis Testing

While confirming PCOS, also measure:

  • Prolactin to exclude hyperprolactinemia 2, 3
  • TSH to rule out thyroid disease 2, 3
  • 17-hydroxyprogesterone to exclude non-classic congenital adrenal hyperplasia 2, 3
  • Fasting glucose and lipid panel for metabolic screening, as all women with PCOS should be screened for type 2 diabetes and dyslipidemia 2

References

Guideline

Diagnostic Workup for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria and Treatment Options for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperandrogenism Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.